Quick Takeaways
- Axonics, Inc. has 13 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 13 Insiders of Axonics, Inc.
- Location
- Irvine, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Axonics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Danny L. Dearen | President & CFO | $1,640,658 | Mixed | 29 Sep 2023 | ||
| Ph.D John Woock | EVP, Chief Mktg/Strtgy Officer | $0 | Mixed | 15 Nov 2024 | ||
| Karen Noblett | Chief Medical Officer | $0 | Mixed | 15 Nov 2024 | ||
| Raymond W. Cohen | Chief Executive Officer, Director | $0 | Mixed | 15 Nov 2024 | ||
| Jane E. Kiernan | Director | $0 | Mixed | 15 Nov 2024 | ||
| Michael H. Carrel | Director | $0 | Mixed | 15 Nov 2024 | ||
| David M. Demski | Director | $0 | Mixed | 15 Nov 2024 | ||
| Robert McNamara | Director | $0 | Mixed | 15 Nov 2024 | ||
| Kari Leigh Keese | Chief Financial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Alfred J. Ford Jr. | Chief Commercial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Esteban Lopez | Director | $0 | Mixed | 15 Nov 2024 | ||
| Rinda Sama | Chief Operating Officer | $0 | Mixed | 15 Nov 2024 | ||
| Nancy Lynn Snyderman MD | Director | $0 | Mixed | 15 Nov 2024 |
Top shareholders of Axonics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Danny L. Dearen |
3/4/5
|
President & CFO |
—
class O/S missing
|
23,777
|
$1,640,658 | — | 29 Sep 2023 |
Recent Insider Transactions by Companies or Individuals for Axonics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.